文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

围术期液体蓄积对肠道收缩力的损害程度与腹膜炎和内毒素血症相似

Perioperative Fluid Accumulation Impairs Intestinal Contractility to a Similar Extent as Peritonitis and Endotoxemia.
PubMed 文献 · Shock · 2018-01-01
一句话结论猪实验显示,高容量液体复苏(20 mL/kg/h)本身即可损害空肠收缩力,程度与腹膜炎、内毒素血症相似,即使肠道灌注保留。

该研究将猪随机分为内毒素血症组(n=16)、腹膜炎组(n=16)和假手术组(n=16),每组再接受高容量(20 mL/kg/h)或中等容量(10 mL/kg/h)液体复苏24小时或至死亡。结果显示,尽管所有组肠道灌注均保留,两个腹膜炎组和两个内毒素血症组的空肠收缩力均受损,假手术组接受高容量而非中等容量液体复苏时也出现类似损害(模型-液体-收缩交互作用 P=0.036;最大收缩力 136±28% vs 170±74% 基线)。一氧化氮合酶抑制(NOS-I)降低收缩力(收缩-抑制交互作用 P=0.011),组间无显著差异;松弛功能不受腹膜炎、内毒素血症或液体方案影响。作者认为围术期高容量液体复苏可能影响术后恢复。

要点

  • 猪实验中,高容量液体复苏(20 mL/kg/h)使假手术组空肠收缩力受损,程度与腹膜炎、内毒素血症组相似(最大收缩力 136±28% vs 170±74% 基线,交互作用 P=0.036)。
  • 所有组肠道灌注均保留,提示收缩力损害并非由灌注不足所致。
  • 两个腹膜炎组和两个内毒素血症组空肠收缩力均受损,且腹膜炎与内毒素血症之间程度相似。
  • 一氧化氮合酶抑制(NOS-I)降低收缩力(交互作用 P=0.011),组间无显著差异。
  • 松弛功能不受腹膜炎、内毒素血症或液体方案影响。

适用人群与场景

  • 猪实验模型,随机分为内毒素血症组(n=16)、腹膜炎组(n=16)和假手术组(n=16),每组再接受高容量(20 mL/kg/h)或中等容量(10 mL/kg/h)液体复苏24小时或至死亡。

研究设计与关键结果

  • 研究类型为随机对照动物实验,比较内毒素血症、腹膜炎和假手术,以及高容量(20 mL/kg/h)与中等容量(10 mL/kg/h)液体复苏。
  • 死亡率分别为:腹膜炎高容量组88%、内毒素血症高容量组75%、腹膜炎中等容量组50%、内毒素血症中等容量组和假手术高容量组13%、假手术中等容量组0%。
  • 尽管所有组肠道灌注均保留,两个腹膜炎组和两个内毒素血症组的空肠收缩力均受损,假手术组接受高容量而非中等容量液体复苏时也出现类似损害(模型-液体-收缩交互作用 P=0.036)。
  • 最大收缩力:两个腹膜炎组、两个内毒素血症组和假手术高容量组的平均值为 136±28% 基线,假手术中等容量组为 170±74% 基线。
  • NOS-I 降低收缩力(收缩-抑制交互作用 P=0.011),组间无显著差异;松弛功能不受腹膜炎、内毒素血症或液体方案影响。

证据类型、等级与局限

  • 证据类型:随机对照动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,围术期高容量液体复苏在假手术动物中也降低肠道收缩力,可能对术后恢复有影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Perioperative resuscitation with large amounts of fluid may cause tissue edema, especially in the gut, and thereby impairing its functions. This is especially relevant in sepsis where capillaries become leaky and fluid rapidly escapes to the pericapillary tissue. We assessed the effects of endotoxemia and peritonitis, and the use of high and moderate volume fluid resuscitation on jejunal contractility. We hypothesized that both endotoxemia and peritonitis impair jejunum contractility and relaxation, and that this effect is aggravated in peritonitis and with high fluid administration.

METHODS: Pigs were randomized to endotoxin (n = 16), peritonitis (n = 16), or sham operation (n = 16), and either high (20 mL/kg/h) or moderate volume (10 mL/kg/h) fluid resuscitation for 24 h or until death. At the end of the experiment, jejunal contractility and relaxation were measured in vitro using acetylcholine and sodium nitroprusside reactivity, and the effect of nitric oxide synthase inhibition (NOS-I) was assessed.

RESULTS: Mortality in the respective groups was 88% (peritonitis high), 75% (endotoxemia high), 50% (peritonitis moderate), 13% (endotoxemia moderate and sham operation high), and 0% (sham operation moderate volume resuscitation). Although gut perfusion was preserved in all groups, jejunal contractility was impaired in the two peritonitis and two endotoxemia groups, and similarly also in the sham operation group treated with high but not with moderate volume fluid resuscitation (model-fluid-contraction-interaction, P = 0.036; maximal contractility 136 ± 28% [average of both peritonitis, both endotoxemia and sham operation high-volume groups) vs. 170 ± 74% of baseline [sham operation moderate-volume group]). NOS-I reduced contractility (contraction-inhibition-interaction, P = 0.011) without significant differences between groups and relaxation was affected neither by peritonitis and endotoxemia nor by the fluid regimen.

CONCLUSIONS: Intestinal contractility is similarly impaired during peritonitis and during endotoxemia. Moreover, perioperative high-volume fluid resuscitation in sham-operated animals also decreases intestinal contractility. This may have consequences for postoperative recovery.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Gorrasi J, Jakob SM, Tovar L, et al. Perioperative Fluid Accumulation Impairs Intestinal Contractility to a Similar Extent as Peritonitis and Endotoxemia. Shock. 2018. PMID: 29251668. doi:10.1097/SHK.0000000000001088

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。